Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Personalized single-cell proteogenomics to distinguish acute myeloid leukemia from nonmalignant clonal hematopoiesis

Dillon, L.W. et al.
Blood Cancer Discovery (2021)

Genetic mutations associated with acute myeloid leukemia (AML) also occur in agerelated clonal hematopoiesis, often in the same individual. This makes confident assignment of detected variants to malignancy challenging. The issue is particularly crucial for AML posttreatment measurable residual disease monitoring, where results can be discordant between genetic sequencing and flow cytometry. We show here that it is possible to distinguish AML from clonal hematopoiesis and to resolve the immunophenotypic identity of clonal architecture. To achieve this, we first design patient-specific DNA probes based on patient’s whole-genome sequencing and then use them for patient-personalized single-cell DNA sequencing with simultaneous single-cell antibody–oligonucleotide sequencing. Examples illustrate AML arising from DNMT3A- and TET2-mutated clones as well as independently. The ability to personalize single-cell proteogenomic assessment for individual patients based on leukemia-specific genomic features has implications for ongoing AML precision medicine efforts.


Dillon, L.W., Ghannam, J., Nosiri, C., Gui, G., Goswami, M., Calvo, K.R., Lindblad, K.E., Oetjen, K.A., Wilkerson, M., Soltis, A.R., Sukumar, G., Dalgard, C.L., Thompson, J., Valdez, J., DeStefano, C.B., Lai1, C., Sciambi, A., Durruthy-Durruthy, R., Llanso, A, Gulati, S, Wang, S., Ooi, A., Dagur, P.K., McCoy, J.P., Burr, P., Li, Y., Hourigan, C.S.


Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms
Luque Paz, Damien
Massively parallel base editing to map variant effects in human hematopoiesis
Jorge D. Martin-Rufino
Spectrum of clonal hematopoiesis in VEXAS syndrome
Fernanda Gutierrez-Rodrigues
Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells
Inge van der Werf
Cell Reports Medicine